A multiple dose study of prasugrel (CS-747), a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humans - Jakubowski, JA; Matsushima, N; Asai, F (Br J Clin Pharmacol, 2007)
et al.